Where is the Fundamental logical error? The company
Where is the Fundamental logical error? The company raised money through PIPE funding. This resulted in a cash balance on their Balance Sheet. The money was spent over 4 years in 8M in P&E and the balance (50M in other expenses). Notably SG&A. At 3M/quarter, that is 12M/year... that is about right. That is where the money went. Why don't you ask management where all that SG&A went to??? huh?
They say that a loss is not a loss until you sell. True. that money was funded out of the losses that are NOW BEING REALIZED, and have been realized for years.
How could the money have gone to the MMs? All they do is make a market. They may trade for their own account, I don't know... They sure hae nothing to do with SG&A. The company doe snot pay the MM's out of the SG&A. I have never seen that line item in a Financial Statement.
And whoa re the "players with inside connections"? You mean posters being paid? Positie posters? Consultants? All part of the SG&A. Ask management. They spent the money. They paid them.
How exactly did it go to MM's . They may be market participants to a
Plastic2Oil, Inc. (PTOI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Key Disclosure on Voting Rights and Shares As a reputable leader in stationery and consumer products, BIC is committed to transparency. Recently, they provided crucial insights into their corporate structure, particularly regarding the total number of voting rights and shares. This disclosure highlights the ongoing dedication towards maintaining clear communication with...
Continue Reading
AGCO (NYSE: AGCO) is strutting its stuff at the 2026 Commodity Classic in San Antonio from February 25-27. Picture this: over 24,000 square feet jam-packed with cutting-edge agricultural machinery aimed at farmers who want to boost their operations. Yeah, the buzz is all about showcasing their big guns like Fendt®, Massey Ferguson®, and PTx™—but dig deeper into...
Continue Reading
Revolutionizing Healthcare Marketing with Ignite Pulse Solutions In the shifting landscape of healthcare marketing, WebMD Ignite introduces a significant enhancement aimed at assisting health systems in thriving amidst the challenges posed by AI and budget constraints. Presenting Ignite Pulse™, this groundbreaking solution offers a comprehensive growth strategy designed...
Continue Reading
Eupraxia Pharmaceuticals Expands Leadership Team Eupraxia Pharmaceuticals Inc. (TSX: EPRX) (NASDAQ: EPRX), known for its innovative approaches in drug delivery technology, has recently announced two significant additions to its leadership. Dr. Amanda Malone has been appointed as the Chief Operating and Scientific Officer, alongside Dr. Rahul Sarugaser as Executive Vice...
Continue Reading
Illumina's Latest Developments in Oncology In an exciting development, Illumina Inc. (NASDAQ: ILMN) has announced a significant expansion in its clinical oncology portfolio. This move aims to set a new standard of care and enhance access to precision therapies through advanced genomic profiling. Following the recent FDA approval of Illumina's TSO Comprehensive test, the...
Continue Reading